What is Addition Technology?
Addition Technology operates as a critical player in the medical device landscape, specializing in the development and manufacturing of FDA-approved intracorneal segments, most notably the Intacs product line. The company maintains rigorous quality standards through its ISO13485 certified facilities, ensuring that every device meets stringent regulatory requirements for both human and veterinary applications. By fostering deep collaborations with ophthalmologists and leading research institutions, Addition Technology bridges the gap between clinical innovation and patient-centric vision care. Their dual-market approach, serving both human vision stabilization and veterinary ophthalmic needs, provides a diversified revenue stream that distinguishes them from traditional single-focus medical device manufacturers.
How much funding has Addition Technology raised?
Addition Technology has raised a total of $67K across 1 funding round:
Debt
$67K
Debt (2021): $67K with participation from PPP
Key Investors in Addition Technology
PPP
Public-Private Partnership
What's next for Addition Technology?
With the recent influx of capital, Addition Technology is poised to accelerate its research and development pipeline, focusing on the next generation of vision correction technologies. The company is expected to leverage these resources to expand its global distribution footprint and enhance its manufacturing capacity to meet rising demand. As the firm transitions through its current growth phase, the focus will likely remain on deepening its clinical partnerships and exploring new therapeutic applications for its proprietary segment technology. This strategic roadmap aims to solidify the company's reputation as a leader in ophthalmic innovation while maintaining the high regulatory compliance standards that have defined its market presence to date.
See full Addition Technology company page
